Additional Supporting Information may be found in the online version of this article.

lt23687-sup-0001-suppfig1.tif1520KSupplemental Figure 1: Percentage of patients with multiple DSAs.
lt23687-sup-0002-supptab1.doc27KSupporting Table 1: Correlation between T- and B-cell cytotoxic crossmatch and single antigen beads analysis.
lt23687-sup-0003-supptab2.doc31KSupporting Table 2: Percentage of patients with rejection ever by preformed DSA status. Median time to first rejection and interquartile ranges are calculated only on patients with rejection.
lt23687-sup-0004-supptab3.doc35KSupporting Table 3: Univariate analysis of predictors of patient survival were undertaken on the entire cohort (1270 patients) and reported if the p<0.2. These predictors were entered into stepwise multivariable modeling and only those factors with a p < 0.05 were kept in the final model (see Figure 3).
lt23687-sup-0005-supptab4.doc33KSupporting Table 4: (A) Risk for rejection and death based on MELD score. (B) Risk for death in patients with and without preformed DSA.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.